About Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli"
Gli Ospedali riuniti "Bianchi-Melacrino", meglio noti come Ospedali Riuniti, costituiscono uno dei più grandi ospedali meridionali. È il principale presidio ospedaliero della città di Reggio Calabria facente parte del Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli"
During the past decade, Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli""
#1 collaborator was "Study Alliance Leukemia (SAL) Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli"
According to Clinical.Site data, the most researched conditions in "Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli"" are
"Chronic Myeloid Leukemia" (5 trials), "Acute Lymphoblastic Leukemia" (3 trials), "Leukemia" (3 trials), "BCR-ABL Positive" (2 trials) and "Chronic Lymphocytic Leukemia" (2 trials). Many other conditions were trialed in "Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli"" in a lesser frequency.
Clinical Trials Intervention Types at Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli"
Most popular intervention types in "Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli"" are "Drug" (22 trials), "Other" (5 trials), "Procedure" (3 trials), "Behavioral" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Nilotinib" (4 trials), "Dasatinib" (2 trials), "Ibrutinib" (2 trials), "Imatinib" (2 trials) and "Ofatumumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli"
The vast majority of trials in "Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli"" are
31 trials for "All" genders.
Clinical Trials Status at Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli"
Currently, there are NaN active trials in "Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli"".
undefined are not yet recruiting,
3 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli",
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli", 0 "Phase 1"
clinical trials were conducted, 15 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".